|
Pharmaceutical product name |
Trade name |
Company |
Target |
FDA/NMPA approval time |
|
Ustekinumab |
Stelara |
J & J |
IL-12/23 |
2009/2019 |
|
Tildrakizumab |
Ilumya |
MSD, Sun Pharmaceutical |
IL-23 |
2018 |
|
Certolizumab |
Cimzia |
UCB |
TNF-ɑ |
2008 |
|
Guselkumab |
Tremfya |
J & J |
IL-23 |
2017 |
|
Secukinumab |
Cosentyx |
Novartis |
IL-17A |
2015/2019 |
|
Ixekizumab |
Taltz |
Eli Lilly |
IL-17A |
2017 |
|
Brodalumab |
Siliq |
Valeant |
IL-17R |
2017 |
|
Apremilast |
Otezla |
Celgene |
PDE-4 |
2014 |
